APP and Alzheimer disease: However, before this chapter can be closed, additional studies are needed to determine the degree to which pharmacological clearance of toxic AβPP-Aβ or preventing its formation and accumulation in brain can preserve or restore cognitive function and slow progression of AD neurodegeneration.